75 filings
Page 2 of 4
8-K
j0wkicu4
11 Oct 23
Departure of Directors or Certain Officers
10:02am
8-K
e0xmxgo043l gyzd
7 Sep 23
Departure of Directors or Certain Officers
11:17am
NT 10-Q
3pl8el
14 Aug 23
Notice of late quarterly filing
11:55am
8-K
1c0hcabbi6tyw0r5v w5
24 Jul 23
BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:28pm
424B4
9ke2 vb8qmzr
21 Jul 23
Prospectus supplement with pricing info
3:37pm
CERT
vgg8 3a0de
20 Jul 23
Certification of approval for exchange listing
12:28pm
8-K
mjxqjhg0lqxr hs4
20 Jul 23
Material Modifications to Rights of Security Holders
11:29am
EFFECT
f1vmjp4t4mime83vro
20 Jul 23
Notice of effectiveness
12:15am
8-A12B
btorw7xle8e6ibn587ht
19 Jul 23
Registration of securities on exchange
2:35pm
DEF 14C
7pjz80ry
17 May 23
Information statement
9:07am
DEFR14C
83a3z
10 Mar 23
Revised information
10:34am
DEF 14C
n1wy5vs3
21 Feb 23
Information statement
4:16pm
PRE 14C
48so80 1xd
10 Feb 23
Preliminary information
1:18pm